(SNX) Synnex - Overview
Stock: Endpoint Solutions, Data Center Tech, Value-Added Services, Cloud Services
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.35% |
| Yield on Cost 5y | 2.16% |
| Yield CAGR 5y | 21.79% |
| Payout Consistency | 93.1% |
| Payout Ratio | 13.6% |
| Risk 5d forecast | |
|---|---|
| Volatility | 26.1% |
| Relative Tail Risk | -9.03% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.63 |
| Alpha | 5.42 |
| Character TTM | |
|---|---|
| Beta | 1.050 |
| Beta Downside | 0.871 |
| Drawdowns 3y | |
|---|---|
| Max DD | 33.78% |
| CAGR/Max DD | 0.62 |
Description: SNX Synnex January 04, 2026
TD SYNNEX (NYSE: SNX) is a global IT distributor and solutions aggregator that sells a broad portfolio of endpoint hardware (PCs, peripherals, mobile devices, printers) and advanced data-center technologies (hybrid-cloud, security, storage, networking, servers, converged & hyper-converged infrastructure). It also delivers value-added services such as design-integration testing, logistics, depot repair, financing (net terms, leasing, floor-plan), device-as-a-service, and marketing support for a diverse reseller base that includes VARs, system integrators, MSPs, government and corporate channels.
Key operating metrics (FY 2023) show revenue of roughly $27.5 billion, a modest operating margin of ≈ 2.5 % and a cash-flow conversion rate near 90 %, reflecting the capital-intensive nature of the distribution business. The segment most sensitive to macro trends is the advanced-solutions line, which has been growing at a 7-9 % CAGR driven by enterprise migration to hybrid-cloud and edge-computing workloads. A sector-wide driver is the ongoing consolidation of the IT channel, where larger distributors capture higher share of high-margin services as vendors push direct-to-customer models.
For a deeper quantitative view of SNX’s valuation, the ValueRay platform offers a concise dashboard worth checking.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 827.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 0.61 > 1.0 |
| NWC/Revenue: 6.92% < 20% (prev 7.02%; Δ -0.10% < -1%) |
| CFO/TA 0.04 > 3% & CFO 1.53b > Net Income 827.7m |
| Net Debt (2.18b) to EBITDA (1.83b): 1.19 < 3 |
| Current Ratio: 1.21 > 1.5 & < 3 |
| Outstanding Shares: last quarter (80.9m) vs 12m ago -4.24% < -2% |
| Gross Margin: 6.50% > 18% (prev 0.06%; Δ 643.7% > 0.5%) |
| Asset Turnover: 193.7% > 50% (prev 193.1%; Δ 0.67% > 0%) |
| Interest Coverage Ratio: 3.96 > 6 (EBITDA TTM 1.83b / Interest Expense TTM 356.6m) |
Altman Z'' 1.58
| A: 0.13 (Total Current Assets 25.29b - Total Current Liabilities 20.96b) / Total Assets 34.25b |
| B: 0.10 (Retained Earnings 3.44b / Total Assets 34.25b) |
| C: 0.04 (EBIT TTM 1.41b / Avg Total Assets 32.26b) |
| D: 0.12 (Book Value of Equity 3.06b / Total Liabilities 25.80b) |
| Altman-Z'' Score: 1.58 = BB |
Beneish M -3.09
| DSRI: 1.05 (Receivables 12.68b/11.30b, Revenue 62.51b/58.45b) |
| GMI: 0.93 (GM 6.50% / 6.05%) |
| AQI: 0.88 (AQ_t 0.25 / AQ_t-1 0.28) |
| SGI: 1.07 (Revenue 62.51b / 58.45b) |
| TATA: -0.02 (NI 827.7m - CFO 1.53b) / TA 34.25b) |
| Beneish M-Score: -3.09 (Cap -4..+1) = AA |
What is the price of SNX shares?
Over the past week, the price has changed by +8.01%, over one month by +12.96%, over three months by +14.60% and over the past year by +21.08%.
Is SNX a buy, sell or hold?
- StrongBuy: 5
- Buy: 5
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the SNX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 179.7 | 4.9% |
| Analysts Target Price | 179.7 | 4.9% |
| ValueRay Target Price | 195.7 | 14.2% |
SNX Fundamental Data Overview February 07, 2026
P/E Forward = 11.534
P/S = 0.2233
P/B = 1.5705
P/EG = 1.048
Revenue TTM = 62.51b USD
EBIT TTM = 1.41b USD
EBITDA TTM = 1.83b USD
Long Term Debt = 3.59b USD (from longTermDebt, last quarter)
Short Term Debt = 1.02b USD (from shortTermDebt, last quarter)
Debt = 4.61b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.18b USD (from netDebt column, last quarter)
Enterprise Value = 16.13b USD (13.96b + Debt 4.61b - CCE 2.44b)
Interest Coverage Ratio = 3.96 (Ebit TTM 1.41b / Interest Expense TTM 356.6m)
EV/FCF = 11.61x (Enterprise Value 16.13b / FCF TTM 1.39b)
FCF Yield = 8.61% (FCF TTM 1.39b / Enterprise Value 16.13b)
FCF Margin = 2.22% (FCF TTM 1.39b / Revenue TTM 62.51b)
Net Margin = 1.32% (Net Income TTM 827.7m / Revenue TTM 62.51b)
Gross Margin = 6.50% ((Revenue TTM 62.51b - Cost of Revenue TTM 58.45b) / Revenue TTM)
Gross Margin QoQ = 6.44% (prev 6.73%)
Tobins Q-Ratio = 0.47 (Enterprise Value 16.13b / Total Assets 34.25b)
Interest Expense / Debt = 1.79% (Interest Expense 82.5m / Debt 4.61b)
Taxrate = 20.13% (62.6m / 311.0m)
NOPAT = 1.13b (EBIT 1.41b * (1 - 20.13%))
Current Ratio = 1.21 (Total Current Assets 25.29b / Total Current Liabilities 20.96b)
Debt / Equity = 0.55 (Debt 4.61b / totalStockholderEquity, last quarter 8.45b)
Debt / EBITDA = 1.19 (Net Debt 2.18b / EBITDA 1.83b)
Debt / FCF = 1.57 (Net Debt 2.18b / FCF TTM 1.39b)
Total Stockholder Equity = 8.32b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.57% (Net Income 827.7m / Total Assets 34.25b)
RoE = 9.94% (Net Income TTM 827.7m / Total Stockholder Equity 8.32b)
RoCE = 11.86% (EBIT 1.41b / Capital Employed (Equity 8.32b + L.T.Debt 3.59b))
RoIC = 8.93% (NOPAT 1.13b / Invested Capital 12.64b)
WACC = 7.71% (E(13.96b)/V(18.57b) * Re(9.78%) + D(4.61b)/V(18.57b) * Rd(1.79%) * (1-Tc(0.20)))
Discount Rate = 9.78% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -5.37%
[DCF Debug] Terminal Value 75.55% ; FCFF base≈1.25b ; Y1≈998.3m ; Y5≈673.5m
Fair Price DCF = 136.2 (EV 13.17b - Net Debt 2.18b = Equity 10.99b / Shares 80.7m; r=7.71% [WACC]; 5y FCF grow -24.13% → 2.90% )
EPS Correlation: 43.51 | EPS CAGR: 6.45% | SUE: 0.57 | # QB: 0
Revenue Correlation: 14.27 | Revenue CAGR: 3.15% | SUE: 0.99 | # QB: 3
EPS next Quarter (2026-05-31): EPS=3.42 | Chg30d=+0.077 | Revisions Net=+7 | Analysts=11
EPS current Year (2026-11-30): EPS=14.63 | Chg30d=+0.140 | Revisions Net=+4 | Growth EPS=+10.9% | Growth Revenue=+4.1%
EPS next Year (2027-11-30): EPS=16.11 | Chg30d=-0.112 | Revisions Net=+0 | Growth EPS=+10.1% | Growth Revenue=+4.2%